Xtl Biopharmaceuticals (XTLB) EPS (Diluted) (QoQ) (2009 - 2024)
Xtl Biopharmaceuticals (XTLB) EPS (Diluted) (QoQ) (2009 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Xtl Biopharmaceuticals | 2.60 Bn | 2.60 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -334.53% |
| Sep 30, 2024 | 391.05% |
| Jun 30, 2024 | -245.15% |
| Mar 31, 2024 | 136.47% |
| Dec 31, 2023 | -232.08% |
| Sep 30, 2023 | 376.65% |
| Jun 30, 2023 | 60.39% |
| Mar 31, 2023 | 40.13% |
| Dec 31, 2022 | -594.56% |
| Sep 30, 2022 | 22.46% |
| Jun 30, 2022 | -501.74% |
| Mar 31, 2022 | 135.62% |
| Dec 31, 2021 | 77.70% |
| Sep 30, 2021 | -175.22% |
| Jun 30, 2021 | 301.64% |
| Mar 31, 2021 | 13,947,967.78% |
| Dec 31, 2020 | 60.00% |
| Sep 30, 2020 | -600.00% |
| Dec 31, 2019 | -56,519,862.89% |
| Sep 30, 2019 | 66.67% |